Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted Therapies in Rare Brain Tumours.

International journal of molecular sciences - 26 Jul 2021

Bruno Francesco, Pellerino Alessia, Bertero Luca, Soffietti Riccardo, Rudà Roberta

Abstract excerpt

Rare central nervous system (CNS) tumours represent a unique challenge. Given the difficulty of conducting dedicated clinical trials, there is a lack of therapies for these tumours supported by high quality evidence, and knowledge regarding the impact of standard treatments (i.e., surgery, radiotherapy or chemotherapy) is commonly based on retrospective studies. Recently, new molecular techniques have led to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Molecular Targeted Therapy
Share to Mutation
Share to Neoplasm Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Rare Diseases

Share to Signal Transduction

Share to Brain Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34360713
DOI: 10.3390/ijms22157949
PMCID: PMC8348084

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted Therapies in Rare Brain Tumours.PMID 34360713Read ↗

Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).Semantic proximity Read ↗

Conventional and emerging treatments of astrocytomas and oligodendrogliomas.Semantic proximity Read ↗

Novel Proteins Regulated by mTOR in Subependymal Giant Cell Astrocytomas of Patients with Tuberous Sclerosis Complex and New Therapeutic ImplicationsSemantic proximity Read ↗

Pediatric low-grade epilepsy-associated tumors (LEATS): neuroimaging review and genetics update.Semantic proximity Read ↗

BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas.Semantic proximity Read ↗

Recent developments in brain tumor predisposing syndromes.Semantic proximity Read ↗

Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.Semantic proximity Read ↗

Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profileSemantic proximity Read ↗

Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis ComplexSemantic proximity Read ↗

Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.Semantic proximity Read ↗

Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.Semantic proximity Read ↗

Nervous system tumors associated with familial tumor syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.